Lightnews — Scholar-powered news

HCPLive @hcplivenews.bsky.social · 1d

New real-world data show that subcutaneous immunotherapy with depigmented, polymerized cat extract improves quality of life and reduces rescue medication use in adults with moderate to severe cat allergy. www.hcplive.com/view... #CatAllergy

HCPLive @hcplivenews.bsky.social · 1d

ICYMI: Baxdrostat has achieved its primary endpoint of reducing ambulatory 24-hour systolic blood pressure in patients with treatment-resistant hypertension. Parent company AstraZeneca plans to share the full Bax24 trial results in November 2025.

Read more: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 1d

We spoke with Anju Peters, MD, director of Clinical Research in the Division of Allergy and Immunology at Northwestern University Feinberg School of Medicine, about the significance of EVEREST and what the results mean for clinicians managing CRSwNP. Watch now:

EVEREST: Dupilumab Outperforms Omalizumab in Head-to-Head CRSwNP Trial, with Anju Peters, MD | HCPLive

Peters emphasized how the new findings reinforce treatment strategies for chronic rhinosinusitis with nasal polyps.

www.hcplive.com

HCPLive @hcplivenews.bsky.social · 1d

Data from the phase 3 LUCENT-3 open-label extension study establish mirikizumab-mrkz (Omvoh) as the first and only IL-23p19 to help patients with moderately to severely active ulcerative colitis achieve sustained, long-term outcomes through 4 years.
Learn more: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 1d

A new trial found that an educational intervention boosted pediatricians’ adherence to early peanut introduction guidelines, rising to 83.7% for low-risk infants. www.hcplive.com/view... #PeanutAllergy #FoodAllergy #Allergy

New Intervention Boosts Early Peanut Introduction to Prevent Peanut Allergy | HCPLive

A new trial reveals that educational interventions significantly enhance pediatricians' adherence to guidelines for early peanut introduction.

www.hcplive.com

HCPLive @hcplivenews.bsky.social · 2d

During #HFSA2025, we sat down with Barry Borlaug, MD, to discuss his prespecified analysis of sex differences with tirzepatide for obesity-related heart failure, based on results from the phase 3 SUMMIT trial.

Watch now:

Tirzepatide Affects Men and Women with HFpEF Equally, With Barry Borlaug, MD | HCPLive

A prespecified secondary analysis revealed no difference in male and female patients’ responses to tirzepatide in obesity-related HFpEF.

www.hcplive.com

HCPLive @hcplivenews.bsky.social · 2d

Taladegib was safe and demonstrated promising efficacy in a phase 2a trial in people with idiopathic pulmonary fibrosis (IPF). Read more:

Taladegib Shows Potential to Improve FVC in Idiopathic Pulmonary Fibrosis | HCPLive

The therapy was well-tolerated in the phase 2a ENV-IPF-101 trial, with mostly mild-to-moderate TEAEs related to treatment.

www.hcplive.com

HCPLive @hcplivenews.bsky.social · 2d

New research suggests high intake of both sugar-sweetened beverages and low- or non-sugar-sweetened beverages incurs an increased MASLD risk, encouraging limiting their intake as part of a prevention strategy for liver disease and cardio-renal-metabolic health.

Read more:

Sugar-, Artificially-Sweetened Beverages Both Linked to Increased MASLD Risk | HCPLive

High intake of both sugar-sweetened beverages and low- or non-sugar-sweetened beverages was linked to greater MASLD risk.

www.hcplive.com

HCPLive @hcplivenews.bsky.social · 2d

New research links small intestinal dilation to severe abdominal symptoms in adults with #FPIES. An 8-question evaluation algorithm may help clinicians assess abdominal distension in these patients.

Small Intestine Dilation Links to Food-Protein-Induced Enterocolitis Syndrome | HCPLive

A recent study reveals that small intestinal dilation significantly contributes to abdominal symptoms in adults with Food-Protein-Induced Enterocolitis Syndrome (FPIES).

www.hcplive.com

HCPLive @hcplivenews.bsky.social · 2d

ICYMI: Following the #FDA approval of roflumilast cream for #AtopicDermatitis, HCPLive spoke with Lawrence Eichenfield, MD, about his team’s findings on the drug and its efficacy.

View: www.hcplive.com/view/signifi...

HCPLive @hcplivenews.bsky.social · 3d

Poor blood glucose control in children with type 1 diabetes may lead to increased risk of neuropathy in adulthood, according to new research from the University of Michigan.

Read more: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 3d

New research is shedding light on increases in short-term kidney function decline following post-COVID-19 vaccination gross hematuria in individuals with IgA nephropathy.

Learn more: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 3d

A new study suggests subcutaneous administration of methotrexate (MTX) for #psoriasis, as opposed to oral administration, may enhance the effectiveness of this drug in patients but also increase their risk of adverse effects.💡

Want to know more?

🔗View: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 3d

In a new study, an educational intervention boosted pediatricians’ adherence to early peanut introduction guidelines, rising to 83.7% for low-risk infants. www.hcplive.com/view...
#PeanutAllergy

New Intervention Boosts Early Peanut Introduction to Prevent Peanut Allergy | HCPLive

A new trial reveals that educational interventions significantly enhance pediatricians' adherence to guidelines for early peanut introduction.

www.hcplive.com

HCPLive @hcplivenews.bsky.social · 3d

Anju Peters, MD, director of Clinical Research in the Division of Allergy and Immunology at Northwestern University Feinberg School of Medicine, discussed the significance of comparing dupilumab and omalizumab and what the results mean for managing CRSwNP.

Watch now: www.hcplive.com/view/dupilum...

HCPLive @hcplivenews.bsky.social · 4d

Come catch up on the most important #ophthalmology news from the third quarter of 2025 with our Q3 recap, collecting FDA approvals, trial updates, and more!

Read now: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 4d

In EVEREST, dupilimab was superior to omalizumab in patients with severe, uncontrolled CRSwNP, although both biologics were well-tolerated and efficacious. Hear more from Anju Peters, MD @northwesternmed now: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 4d

Following the #FDA approval of roflumilast cream for #AtopicDermatitis, HCPLive spoke with Lawrence Eichenfield, MD, about his team’s findings on the drug and its efficacy.

View:

Significance of Roflumilast Approval for Atopic Dermatitis in Children, With Lawrence Eichenfield, MD | HCPLive

This interview follows the FDA’s recent approval of Arcutis's roflumilast (Zoryve) cream 0.05% for patients aged 2-5 years with atopic dermatitis.

www.hcplive.com

HCPLive @hcplivenews.bsky.social · 4d

Following FDA approval, #donidalorsen (Dawnzera) shows strong efficacy and safety in patients switching from other #HAE prophylactic therapies.
William Lumry, MD, discusses pivotal switch data and real-world impact: www.hcplive.com/view/switchi...

HCPLive @hcplivenews.bsky.social · 5d

From FDA decisions to key trial data, we've collected the most crucial headlines in cardiology from the last 3 months: catch up on what you missed with our Q3 2025 recap!

Read now: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 5d

New data from the LUCENT-3 open-label extension study establish mirikizumab (Omvoh) as the first and only IL-23p19 to help patients with moderately to severely active ulcerative colitis achieve sustained, long-term outcomes through 4 years.

Read more: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 5d

In a new study, secukinumab and ixekizumab had similar clinical efficacy in treating moderate-to-severe #psoriasis, but secukinumab was shown to offer superior psychological benefits.

View here: www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 5d

The FDA has approved donidalorsen (Dawnzera)—the first RNA-targeted therapy for hereditary angioedema (HAE).
In an interview with Dr. William Lumry, he discusses how targeting prekallikrein opens a new path in HAE prevention.
www.hcplive.com/view...

HCPLive @hcplivenews.bsky.social · 5d

We spoke with Vimal H. Prajapati, MD, from @University of Calgary about the new FDA approval of guselkumab for pediatric psoriasis and psoriatic arthritis. Learn more about how the new approval's impact in the field now:
www.hcplive.com/view/bridgin...

HCPLive @hcplivenews.bsky.social · 6d

Come catch up on some of the most important #cardiology news with our Month in Review! From FDA approvals to professional insights, we've collected some unmissable headlines from September 2025.

Read now: www.hcplive.com/view...

1